共 396 条
[1]
Collaborators GDIIP(2016)Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the global burden of disease study 2015 Lancet. 388 1545-1602
[2]
Chavan S(2014)International variations in bladder cancer incidence and mortality Eur Urol 66 59-73
[3]
Bray F(2014)Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer Nat Rev Urol 11 400-410
[4]
Lortet-Tieulent J(2014)Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes Cell Rep 9 1235-1245
[5]
Goodman M(2014)Comprehensive molecular characterization of urothelial bladder carcinoma Nature. 507 315-322
[6]
Jemal A(2017)Oncogenic characterization and pharmacologic sensitivity of activating fibroblast growth factor receptor (FGFR) genetic alterations to the selective FGFR inhibitor Erdafitinib Mol Cancer Ther 16 1717-1726
[7]
Choi W(2017)Comprehensive molecular characterization of muscle-invasive bladder Cancer Cell. 171 540-556 e525
[8]
Czerniak B(2014)Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy Cancer Cell 25 152-165
[9]
Ochoa A(2016)FOXA1, GATA3 and PPAR cooperate to drive luminal subtype in bladder Cancer: a molecular analysis of established human cell lines Sci Rep 6 1109.e1101-1109.e1106
[10]
Su X(2013)Higher expression of peroxisome proliferator-activated receptor gamma or its activation by agonist thiazolidinedione-rosiglitazone promotes bladder cancer cell migration and invasion Urology. 81 6987-6998